Merck sues Biden administration over Medicare drug price negotiations

In a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a "sham" and "tantamount to extortion."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.